NeuroOne reports preliminary Q1 FY2025 revenue of $6.2M, up from $1.0M YoY

NEUROONE MEDICAL TECHNOLOGIES Corp

2025-Q1 EPS reported $0.06 revenue$3,274,167

Preliminary unaudited Q1 FY2025 total revenue $6.2M vs $1.0M in Q1 FY2024.
Includes $3.0M one-time collaboration revenue from Zimmer Biomet expanded distribution agreement.
Product revenue $3.2M, up 227% YoY from $1.0M.
Reiterates FY2025 product revenue guidance $8-10M, product gross margin 47-51%.
Virtual investor webinar held Jan 10, 2025 at 11am ET.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.